TIMOTHY TYSON
CIK 1207405 · CEO and President · last filed 2024-06-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13
Companies
3
Total Filings
27
Lifetime Open-Market Net
$101.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Director | 33,189 | $0.00 | $13 | $106.0K | 5 | 2024-06-07 |
| TYME TECHNOLOGIES, INC. (TYME) Delisted | Director | 0 | $0.31 | $0 | $0 | 8 | 2022-09-16 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | CEO and President | 118,496 | — | — | -$4.9K | 2 | 2007-11-01 |
Recent Filings · Page 3 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-14 | — | Grant (A) | — | $0 | |
| 2017-03-16 | — | Grant (A) | — | $0 | |
| 2016-07-07 | — | Grant (A) | — | $0 | |
| 2016-05-20 | — | Grant (A) | — | $0 | |
| 2015-01-09 | — | Grant (A) | +285,712 | $0 | |
| 2007-11-01 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +105,000 | $1.55M | EDGAR |
| 2007-06-06 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Sell (S) | −300 | -$4.9K | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.